NHS SHARED BUSINESS SERVICES LIMITED

1. Credit Opinion: CONDITIONAL

Reasoning: While the entity exhibits a very low probability of default due to its structural backing by the UK Government (Secretary of State for Dept of Health) and a major corporate partner (Sopra Steria Limited), the credit opinion is rated Conditional due to the absence of quantitative financial data in the provided file. The company is a 50/50 Joint Venture (based on PSC disclosures) providing critical IT services to the NHS. This quasi-sovereign status provides exceptional implicit support. However, the filed share capital is nominal (£11,003), and without sight of the full profit and loss accounts, cash flow statements, or current balance sheet figures, a quantitative assessment of debt service coverage and leverage is not possible. Approval is recommended subject to review of the latest full audited financial statements.

2. Financial Strength

• Ownership Structure: The company benefits from a "hard" support structure, with ownership split between the Secretary of State for Dept of Health/NHS Business Services Authority and Sopra Steria Limited. This dual backing means that in the event of financial distress, there is a high probability of recapitalisation or support from shareholders with deep pockets (sovereign and investment-grade corporate).
• Capitalization: The share capital is extremely low at £11,003. This is typical for joint ventures of this nature, which often operate with high leverage or intercompany loans rather than subscribed equity. However, it means that the buffer for unsecured creditors is thin on paper.
• Longevity: Incorporated in 2004, the company has a 20-year track record, indicating stability and successful execution of public sector contracts.
• Data Quality Note: The PSC register contains duplicate entries for Sopra Steria and the Secretary of State with overlapping percentage thresholds. This administrative anomaly should be clarified, though it does not obscure the fact that control is effectively split 50/50.

3. Cash Flow Assessment

• Revenue Stability: As a provider of IT consultancy and shared business services to the NHS (SIC 62020), the company likely benefits from recurring, contract-based revenue. Public sector contracts provide high visibility on future cash flows, which supports debt serviceability.
• Working Capital: The nature of public sector IT contracts often involves milestone payments or monthly arrears, which generally reduces trade debtor risk. However, public sector clients can be bureaucratic in payment processing, potentially stretching the cash conversion cycle.
• Liquidity: Without the specific current ratio or net current assets, liquidity cannot be quantified. However, given the shareholders, the risk of insolvency due to short-term liquidity crunches is mitigated by the availability of intercompany facilities or parent guarantees.

4. Monitoring Points

• Financial Filings: The next accounts are due by 30 Sept 2027 (for the period ending 31 Dec 2025). The full accounts must be reviewed to assess actual leverage, profitability margins, and cash generation.
• Contract Retention: The primary risk is the loss or non-renewal of key NHS contracts. Monitoring public procurement portals for contract statuses is essential.
• Intercompany Balances: Review the nature of creditor/debtor balances with Sopra Steria and the NHS to ensure transactions are conducted at arm's length and that the company is not being used as a conduit for cash extraction or debt dumping.
• Government Policy: Changes in NHS funding or IT strategy could impact the business model. Austerity measures could pressure margins.